Cover Image
市場調查報告書

Tris Pharma, Inc.的產品平台分析

Tris Pharma, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 317363
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Tris Pharma, Inc.的產品平台分析 Tris Pharma, Inc. - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 20 Pages
簡介

Tris Pharma, Inc.是總公司位於美國的製藥企業,正在研究開發及製造用於咳嗽,感冒,疼痛管理,神經性疾病治療的OTC藥,RX品牌藥,特殊的非專利產品。

本報告提供Tris Pharma, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Tris Pharma, Inc.的基本資料

  • Tris Pharma, Inc.概要
  • 主要資訊
  • 企業資料

Tris Pharma, Inc.:R&D概要

  • 主要的治療範圍

Tris Pharma, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Tris Pharma, Inc.:開發中產品概況

  • 後期階段產品開發中產品
    • 新藥登記前階段的產品/聯合治療模式
    • 第三階段的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 臨床試驗前階段的產品/聯合治療模式
  • 開發階段不明的開發中產品
    • 開發階段不明的產品/聯合治療模式

Tris Pharma, Inc.:藥物簡介

  • CCP-01
  • TRI-102
  • CCP-07
  • CCP-08
  • CCP-05
  • CCP-06
  • TRI-091
  • TRI-096

Tris Pharma, Inc.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Tris Pharma, Inc.:最新的開發平台資訊

Tris Pharma, Inc.:暫停開發的計劃

Tris Pharma, Inc.:企業理念

Tris Pharma, Inc.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07752CDB

Summary

Global Markets Direct's, 'Tris Pharma, Inc. - Product Pipeline Review - 2015', provides an overview of the Tris Pharma, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Tris Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Tris Pharma, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Tris Pharma, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Tris Pharma, Inc.'s pipeline products

Reasons to buy

  • Evaluate Tris Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Tris Pharma, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Tris Pharma, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Tris Pharma, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tris Pharma, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Tris Pharma, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Tris Pharma, Inc. Snapshot
    • Tris Pharma, Inc. Overview
    • Key Information
    • Key Facts
  • Tris Pharma, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Tris Pharma, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Tris Pharma, Inc. - Pipeline Products Glance
    • Tris Pharma, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Tris Pharma, Inc. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Tris Pharma, Inc. - Drug Profiles
    • TRI-102
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TRI-091
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TRI-096
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Tris Pharma, Inc. - Pipeline Analysis
    • Tris Pharma, Inc. - Pipeline Products by Route of Administration
  • Tris Pharma, Inc. - Recent Pipeline Updates
  • Tris Pharma, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Tris Pharma, Inc., Key Information
  • Tris Pharma, Inc., Key Facts
  • Tris Pharma, Inc. - Pipeline by Indication, 2015
  • Tris Pharma, Inc. - Pipeline by Stage of Development, 2015
  • Tris Pharma, Inc. - Monotherapy Products in Pipeline, 2015
  • Tris Pharma, Inc. - Partnered Products in Pipeline, 2015
  • Tris Pharma, Inc. - Partnered Products/ Combination Treatment Modalities, 2015
  • Tris Pharma, Inc. - Phase III, 2015
  • Tris Pharma, Inc. - Unknown, 2015
  • Tris Pharma, Inc. - Pipeline by Route of Administration, 2015
  • Tris Pharma, Inc. - Recent Pipeline Updates, 2015

List of Figures

  • Tris Pharma, Inc. - Pipeline by Top 10 Indication, 2015
  • Tris Pharma, Inc. - Pipeline by Stage of Development, 2015
  • Tris Pharma, Inc. - Monotherapy Products in Pipeline, 2015
  • Tris Pharma, Inc. - Partnered Products in Pipeline, 2015
  • Tris Pharma, Inc. - Pipeline by Top 10 Route of Administration, 2015
Back to Top